MAOB and Parkinson disease: TRF differentially modulates PD outcomes: in casein-fed mice, it alleviates partial motor deficits by suppressing monoamine oxidase B (MAO-B) and reducing dopamine (DA) metabolism, without rescuing DA levels or neuron survival.